PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 2, 2002, Pages 232-237

  Yang, Dan Hong ^a   Liang, Wei Feng ^a   Xie, Yuan Jun ^a   Zhao, Nian Feng ^a   Fan, Jun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatitis B virus; Lamivudine; PCR RFLR; Polymerase gene; YMDD variants

Indexed keywords

ASPARTIC ACID; DNA POLYMERASE; ENZYME VARIANT; ISOLEUCINE; LAMIVUDINE; METHIONINE; RESTRICTION ENDONUCLEASE; TYROSINE; VIRUS DNA; VIRUS ENZYME;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; PROTEIN MOTIF; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRUCTURAL GENE;

ADOLESCENT; ADULT; AMINO ACID MOTIFS; ASPARTIC ACID; BASE SEQUENCE; CHILD; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; METHIONINE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE INHIBITORS; TYROSINE; VARIATION (GENETICS);

EID: 0038205728     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lai CL, Yuen MF. Profound suppression of hepatitis B virus replication with lamivudine. J Med Virol 2000;61:367-373.
2. Lai CL, Liaw YF, Leung NWY, et al. Genotypic resistance to lamivudine in a prospective, placebo-controlled multicentre study in-Asia of lamivudine therapy for chronic hepatitis B infection incidence, kinetics of emergence, and correlation with disease parameters. Hepatology 1997;6:259.
3. Melegari M, Scglioni PP, Wands JR. Hepatitis B virus mutant associated with 3TC and famiciclovir administration are replication defective. Hepatology 1998;7:628-633.
4. Marchelle IA, Deslauriers M, Andrews CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology 1998;7:1670-1677.
5. Chayama K, Suzuki Y, Kobayashi M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and retake-over by wild type after cessation of therapy. Hepatology 1998;7:1711-1716.
6. Yao GB. Management of hepatitis B in China. J Med Virol 2000;1:392-397.
7. Leung N, Wu PC, Tsang S, et al. Continued histological improvement in Chinese patients with chronic hepatitis B with 2-year lamivudine. Hepatology 1998; 8:163A.
8. Liaw YF, Leung NW, Chang TT, et al. Effects of extend lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group Comments Gastroenterology 2000;9:172-180.
9. Jardi R, Buti M, Frias FR, et al. Rapid detection of lamivudine-resistant hepatitis B -virus polymerase gene variants. Virol Meth 1999;3:181-187.
10. Hou JL, Sun J. Prevention, treatment and detection of hepatitis B virus resistant to nucleoside analogue. Chin Med J 1999;9:806-807.
11. Liaw YF, Chien RN, Yeh CT, et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999;2:567-571.
12. Gauthier J, Bourne EJ, Lutz MW, et al. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis 1999;180:1757-1762.
13. Schalm SW. Clinical implication of lamivudine resistance by HBV. Lancet 1997;349:3-4.
14. Yao G, Wang B, Cui Z. Long-term effect of lamivudine treatment in chronic hepatitis B virus infection. Chung-Hua-Kan-Tsang-Ping-Tsa-Cih 1999;7:80-83.
15. Liaw YF, Chien RN, Yeh CT, et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy [comments]. Hepatology 1999;30:567-572.
16. Lau DT, Khokhar MF, Doo E, et al. Long-term therapy of chronic hepatitis B with lamivudine [comments]. Hepatology 2000;32:828-834.